Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W North

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
Antimicrobial Agents and Chemotherapy|April 1, 1996
Selection and characterization of a mutant of feline immunodeficiency virus resistant to 2',3'-dideoxycytidineH K Medlin, Y Q Zhu, K M Remington, et al.
The Journal of Biological Chemistry|January 5, 2000
Site-specific incorporation of nucleoside analogs by HIV-1 reverse transcriptase and the template grip mutant P157S. Template interactions influence substrate recognition at the polymerase active siteG J Klarmann, R A Smith, R F Schinazi, et al.
Optics Letters|May 19, 2016
Simultaneous three-dimensional velocimetry and thermometry in gaseous flows using the stereoscopic vibrationally excited nitric oxide monitoring techniqueFeng Pan, Rodrigo Sánchez-González, Madison H McIlvoy, et al.
The Journal of Physical Chemistry. A|February 28, 2019
Anomalous Intensities in the 2+1 REMPI Spectrum of the E <sup>1</sup>Π-X <sup>1</sup>Σ<sup>+</sup> Transition of COC E Gunthardt, C J Wallace, G E Hall, et al.
Journal of Virology|March 1, 1997
A novel Met-to-Thr mutation in the YMDD motif of reverse transcriptase from feline immunodeficiency virus confers resistance to oxathiolane nucleosidesR A Smith, K M Remington, R M Lloyd, et al.
Journal of Virology|March 14, 1998
A novel point mutation at position 156 of reverse transcriptase from feline immunodeficiency virus confers resistance to the combination of (-)-beta-2',3'-dideoxy-3'-thiacytidine and 3'-azido-3'-deoxythymidineR A Smith, K M Remington, B D Preston, et al.
The Journal of Chemical Physics|May 24, 2014
A unified model for simulating liquid and gas phase, intermolecular energy transfer: N₂ + C₆F₆ collisionsAmit K Paul, Swapnil C Kohale, Subha Pratihar, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2012
Cellular pharmacology and potency of HIV-1 nucleoside analogs in primary human macrophagesChristina Gavegnano, Mervi A Detorio, Leda Bassit, et al.
Molecular Pharmacology|January 26, 2002
Chimeric human immunodeficiency virus type 1 and feline immunodeficiency virus reverse transcriptases: role of the subunits in resistance/sensitivity to non-nucleoside reverse transcriptase inhibitorsJoeri Auwerx, Thomas W North, Bradley D Preston, et al.
Veterinary Immunology and Immunopathology|August 12, 2003
16alpha-Bromo-epiandrosterone therapy modulates experimental feline immunodeficiency virus viremia: initial enhancement leading to long-term suppressionNiels C Pedersen, Thomas W North, Richard Rigg, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Antimicrobial Agents and Chemotherapy|April 1, 1996
Selection and characterization of a mutant of feline immunodeficiency virus resistant to 2',3'-dideoxycytidineH K Medlin, Y Q Zhu, K M Remington, et al.
The Journal of Biological Chemistry|January 5, 2000
Site-specific incorporation of nucleoside analogs by HIV-1 reverse transcriptase and the template grip mutant P157S. Template interactions influence substrate recognition at the polymerase active siteG J Klarmann, R A Smith, R F Schinazi, et al.
Optics Letters|May 19, 2016
Simultaneous three-dimensional velocimetry and thermometry in gaseous flows using the stereoscopic vibrationally excited nitric oxide monitoring techniqueFeng Pan, Rodrigo Sánchez-González, Madison H McIlvoy, et al.
The Journal of Physical Chemistry. A|February 28, 2019
Anomalous Intensities in the 2+1 REMPI Spectrum of the E <sup>1</sup>Π-X <sup>1</sup>Σ<sup>+</sup> Transition of COC E Gunthardt, C J Wallace, G E Hall, et al.
Journal of Virology|March 1, 1997
A novel Met-to-Thr mutation in the YMDD motif of reverse transcriptase from feline immunodeficiency virus confers resistance to oxathiolane nucleosidesR A Smith, K M Remington, R M Lloyd, et al.
Journal of Virology|March 14, 1998
A novel point mutation at position 156 of reverse transcriptase from feline immunodeficiency virus confers resistance to the combination of (-)-beta-2',3'-dideoxy-3'-thiacytidine and 3'-azido-3'-deoxythymidineR A Smith, K M Remington, B D Preston, et al.
The Journal of Chemical Physics|May 24, 2014
A unified model for simulating liquid and gas phase, intermolecular energy transfer: N₂ + C₆F₆ collisionsAmit K Paul, Swapnil C Kohale, Subha Pratihar, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2012
Cellular pharmacology and potency of HIV-1 nucleoside analogs in primary human macrophagesChristina Gavegnano, Mervi A Detorio, Leda Bassit, et al.
Molecular Pharmacology|January 26, 2002
Chimeric human immunodeficiency virus type 1 and feline immunodeficiency virus reverse transcriptases: role of the subunits in resistance/sensitivity to non-nucleoside reverse transcriptase inhibitorsJoeri Auwerx, Thomas W North, Bradley D Preston, et al.
Veterinary Immunology and Immunopathology|August 12, 2003
16alpha-Bromo-epiandrosterone therapy modulates experimental feline immunodeficiency virus viremia: initial enhancement leading to long-term suppressionNiels C Pedersen, Thomas W North, Richard Rigg, et al.
Pageof 13